{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T08:40:39Z","timestamp":1773218439715,"version":"3.50.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2012027176"],"award-info":[{"award-number":["2012027176"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0195459","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T13:35:41Z","timestamp":1523280941000},"page":"e0195459","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Risk of new-onset diabetes among patients treated with statins according to hypertension and gender: Results from a nationwide health-screening cohort"],"prefix":"10.1371","volume":"13","author":[{"given":"Sang-Eun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Min","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Jeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon Chang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6139-7545","authenticated-orcid":true,"given":"Hyuk-Jae","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,4,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.diabres.2009.10.008","article-title":"Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis","volume":"87","author":"WL Baker","year":"2010","journal-title":"Diabetes research and clinical practice"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.amjcard.2012.12.037","article-title":"Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus","volume":"111","author":"EP Navarese","year":"2013","journal-title":"The American journal of cardiology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"D Preiss","year":"2011","journal-title":"Jama"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.2337\/dc09-0738","article-title":"Statin therapy and risk of developing type 2 diabetes: a meta-analysis","volume":"32","author":"SN Rajpathak","year":"2009","journal-title":"Diabetes care"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"N Sattar","year":"2010","journal-title":"The Lancet"},{"key":"ref6","article-title":"FDA Expands Advice on Statin Risks","author":"U Food","year":"2015","journal-title":"FDA Expands Advice on Statin Risks"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1097\/HJH.0b013e32832be5f9","article-title":"Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension","volume":"27","author":"G Mancia","year":"2009","journal-title":"Journal of hypertension"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJM200003303421310","article-title":"Antihypertensive therapy and the risk of type 2 diabetes mellitus","volume":"342","author":"JR Sowers","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"LH Lindholm","year":"2002","journal-title":"The Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/01.HYP.0000057420.27692.AD","article-title":"Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT)","volume":"41","author":"G Mancia","year":"2003","journal-title":"Hypertension"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"G Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/01.hjh.0000177537.91527.09","article-title":"The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension","volume":"23","author":"JM Mason","year":"2005","journal-title":"Journal of hypertension"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"SE Kahn","year":"2014","journal-title":"The Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"SM Grundy","year":"2005","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial","volume":"380","author":"PM Ridker","year":"2012","journal-title":"The Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jacc.2010.10.047","article-title":"Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials","volume":"57","author":"DD Waters","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/archinternmed.2011.625","article-title":"Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative","volume":"172","author":"AL Culver","year":"2012","journal-title":"Archives of internal medicine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/CIRCULATIONAHA.109.906479","article-title":"Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials","volume":"121","author":"S Mora","year":"2010","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2012.06.001","article-title":"Statins are diabetogenic\u2013myth or reality?","volume":"13","author":"N Sattar","year":"2012","journal-title":"Atherosclerosis Supplements"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijcard.2011.09.002","article-title":"Caveats to aggressive lowering of lipids by specific statins","volume":"154","author":"KK Koh","year":"2012","journal-title":"International journal of cardiology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jamacardio.2016.1884","article-title":"Association of lipid fractions with risks for coronary artery disease and diabetes","volume":"1","author":"J White","year":"2016","journal-title":"JAMA cardiology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e110650","DOI":"10.1371\/journal.pone.0110650","article-title":"The incidence and prevalence of diabetes mellitus and related atherosclerotic complications in Korea: a National Health Insurance Database Study","volume":"9","author":"BK Koo","year":"2014","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4093\/dmj.2013.37.4.233","article-title":"Diabetes epidemics in Korea: reappraise nationwide survey of diabetes "diabetes in Korea 2007"","volume":"37","author":"B Park Ie","year":"2013","journal-title":"Diabetes Metab J."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3803\/EnM.2015.30.2.142","article-title":"Trends in the Diabetes Epidemic in Korea","volume":"30","author":"KH Ha","year":"2015","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"NJ Stone","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-12-51","article-title":"Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis","volume":"12","author":"AF Macedo","year":"2014","journal-title":"BMC medicine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials","volume":"385","author":"CT Trialists","year":"2015","journal-title":"The Lancet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(07)60361-4","article-title":"Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995\u20132005: a population-based study","volume":"369","author":"LL Lipscombe","year":"2007","journal-title":"Lancet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0195459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:07:23Z","timestamp":1540217243000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0195459"}},"subtitle":[],"editor":[{"given":"Lamberto","family":"Manzoli","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,9]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0195459","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,9]]}}}